Astrelis
Dialysis facility · TX

DIALYSIS 672621

CCN 672621Latest FY 2023
Cost-report basis
HCRIS · as filed
Not audited by Astrelis
The read

A dialysis facility in TX. It ran an operating loss of 3.2% in FY23 on $0.3M of operating revenue. Only a single comparable reporting year is available, so trend context is limited.

Operating margin · FY23
-3.2%
vs dialysis facilities23rd pctl of 7,741
Days cash on hand
Not available
vs dialysis facilities
Total operating revenue · FY23
$0.3M
vs dialysis facilities3rd pctl
Total margin · incl. nonoperating · FY23
-3.2%
vs dialysis facilities22nd pctl

Where DIALYSIS 672621 sits among dialysis facilities

Operating margin · FY23 pool · n = 7,741 of 7,741 filed

Each point is one dialysis facility in the national distribution for this provider type, placed by operating margin. Facilities are not matched on size, case mix, or market — that is the matched-peer comparison in the paid benchmark. The dialysis facility median is +11.9%. Descriptive context only, not a ranking.

-20%-10%0%+10%+20%dialysis facility median +11.9%DIALYSIS 672621 -3.2%-20%0%+20%dialysis facility median +11.9%DIALYSIS 672621 -3.2%
One dialysis facilityDIALYSIS 672621dialysis facility median

The money

$ thousands · HCRIS cost-report basis · as filed, QA-gated

Ratios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio renders only when every input is reported in the filing; a year missing its core lines is not shown; a year whose balance sheet does not reconcile is labeled. Not audited by Astrelis.

Operating margin
-3.2% (FY23)
Operating income ÷ total operating revenue
HCRIS WS G-3
Total margin
-3.2% (FY23)
Net income ÷ total revenue incl. nonoperating
HCRIS WS G-3
Days cash on hand
Not reported in this filing
Cash & investments ÷ daily operating expense
HCRIS WS G / G-3
Current ratio
Not shown, balance sheet did not reconcile as filed
Total current assets ÷ current liabilities
HCRIS WS G
Equity financing ratio
Not shown, balance sheet did not reconcile as filed
Total net assets ÷ total assets
HCRIS WS G
Days in net patient A/R
Not shown, balance sheet did not reconcile as filed
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
HCRIS WS G / G-3
$ in thousands
Line itemFY21FY22FY23
Patient revenue1,6202,063309
Total operating revenue1,6202,063309
Total operating expenses1,8842,695319
Operating income(264)(632)(10)
Operating margin %-16.3%-30.6%-3.2%
Other non-operating, net010
Net income(264)(631)(10)
Net income %-16.3%-30.6%-3.2%
HCRIS CMS-265 cost report · $ thousands · FY20–FY23 · operating revenue reflects net patient service revenue · FY20–21 may include COVID-era relief funding

How it operates

quality & operational context · CMS public reporting

The metrics this dialysis facility type is judged on: care quality, patient experience, and scale. Each is labeled by evidence class and public source; descriptive context only, never a ranking or adequacy claim.

Total treatments
751
Verified fact2023
HCRIS CMS-265
Cost per treatment ($)
424.61
Verified fact2023
HCRIS CMS-265
Net revenue per treatment ($)
411.44
Verified fact2023
HCRIS CMS-265

Trajectory

Cost-report basis · 4 reporting years
Operating margin
-18.4%-16.3%-30.6%-3.2%FY20FY21FY22FY23
Days cash on hand
Not available

The county this dialysis facility serves

Location, TX
Median household income
$73.1K
vs $82.1K US · $59.7K rural median
Poverty rate
15.9%
vs 12.5% US · 14.3% rural median
Uninsured
21.2%
vs 8.6% US · 8.4% rural median
Age 65+
11.4%
vs 16.8% US · 20.6% rural median
Fair or poor health
21.8%
self-reported, adults · CDC PLACES
Primary-care shortage
Designated
HRSA HPSA
Economic context: 5.6% of county personal income is Medicare/Medicaid medical benefits; 12.9% arrives as government transfers (BEA, 2022).
build aa21187 · 2026-07-28